Australia's most trusted
source of pharma news
Friday, 05 December 2025
Friday, 5 December 2025
Subscribe
Login
News Headlines
News Headlines
News
TGA considers $4M treatment
Posted 5 December 2025 AM
The TGA is reviewing what could become one the most expensive treatments in Australia - a new form of Novartis' gene therapy Zolgensma, which carries a price tag of $4 million for a one-time dose.
And in what could be a good sign, the treatment for spinal muscular atrophy (SMA) was recently approved by the FDA for the same indication currently under TGA consideration, which includes a different cohort of patients than those covered by the current PBS listing.
To see the whole article, please login
Posted 5 December 2025 AM
The TGA is reviewing what could become one the most expensive treatments in Australia - a new form of Novartis' gene therapy Zolgensma, which carries a price tag of $4 million for a one-time dose.
And in what could be a good sign, the treatment for spinal muscular atrophy (SMA) was recently approved by the FDA for the same indication currently under TGA consideration, which includes a different cohort of patients than those covered by the current PBS listing.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (14)
- Specialist Account Manager - Sydney
- Key Account Manager - Sydney
- Devices Territory Manager - Brisbane
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Customer Service Representative - East Brisbane
- Head of Sales - Melbourne, VIC
- Pharmaceutical Sales Representative - Sydney
- Key Account Manager - Brisbane
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Belrose
Clinical & Medical, R&D (8)
- Medical information and governance associate - Sydney
- Medical Manager - Sydney
- Clinical Research, Business Development Manager - China - Shanghai, China
- Medical Sales Representative - Wollongong
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
- Senior Portfolio Director - Clinical Research, China - Shanghai, China
- Clinical Sales Specialist - Sydney
- Clinical Sales Specialist - Melbourne
Regulatory, Pharmacovigilance & QA (3)
- Regulatory Affairs Specialist - Sydney
- Senior Quality Assurance Associate - Sydney
- Senior Regulatory Affairs Associate - Sydney
Devices (1)
Other (14)
- Finance & Admin Officer - Macquarie Park
- Service Administrator - Belrose
- Warehouse Assistant - Rydalmere
- Freight & Distribution Specialist - Macquarie Park
- Compliance & Legal Director - Macquarie Park
- Technical Service & Warehouse Coordinator - Alexandria
- Finance Business Partner - Surry Hills
- Senior Payroll Officer - Melbourne
- Head of People and Culture - Kingsgrove
- TM - QLD South Consumables - Brisbane
- Commercial Lead - Melbourne
- Senior Recruitment Consultant - Sydney
- Warehouse Assistant - Macquarie Park
- Senior Recruitment Consultant - Sydney
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.